|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CA |
First Approval Date20 Mar 2018 |
|
Mechanismfungal CYP51A1 inhibitors |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date06 Mar 2015 |
100 Clinical Results associated with Avir Pharma, Inc.
0 Patents (Medical) associated with Avir Pharma, Inc.
100 Deals associated with Avir Pharma, Inc.
100 Translational Medicine associated with Avir Pharma, Inc.